Sort
261,768 grants matching “gene therapy”
Statistical Methods for Integrative Genomics in Cancer
$2,497,918William James Gauderman · University Of Southern California · P01 · FY2025 · CA
Cryptic gut bacterial metabolites that regulate colorectal cancer formation
$2,497,500Jason Michael Crawford · Yale University · DP2 · FY2013 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,497,111Robert A Britton · Baylor College Of Medicine · U19 · FY2024 · AI
SPORE in Ovarian Cancer
$2,496,726Ie-Ming Shih · Johns Hopkins University · P50 · FY2024 · CA
Reactive oxygen species and anti-oxidants in ALI
$2,496,699Aron B. Fisher · University Of Pennsylvania · P01 · FY2009 · HL
Role of microbiome in cancer and inflammation
$2,496,470Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeted Therapies in Melanoma
$2,496,009Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
T Cell Costimulatory Pathways: Functions and Interactions
$2,495,776Arlene H Sharpe · Harvard Medical School · P01 · FY2020 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,495,776Arlene H Sharpe · Harvard Medical School · P01 · FY2022 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,495,776Arlene H Sharpe · Harvard Medical School · P01 · FY2021 · AI
T Cell Costimulatory Pathways: Functions and Interactions
$2,495,776Arlene H Sharpe · Harvard Medical School · P01 · FY2023 · AI
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$2,495,409Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
$2,495,260Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2017 · AG
Growth Factor Imaging and Photoimmunotherapy
$2,495,095Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$2,494,955Howard Feldman · University Of California, San Diego · R01 · FY2023 · AG
Studies of the Natural History of Sickle Cell Disease
$2,494,416Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Experimental Therapy for Brain Tumors
$2,494,255David M. Ashley · Duke University · P01 · FY2022 · CA
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,494,008Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2020 · HL
Center for Cell-based Therapy - Cures
$2,493,170Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pathway Analysis in Tuberculosis
$2,492,917Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$2,492,814Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$2,492,623Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
IMPROVING CORD BLOOD TRANSPLANTATION
$2,492,597Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
SPORE in Ovarian Cancer
$2,492,537Ie-Ming Shih · Johns Hopkins University · P50 · FY2018 · CA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,492,476Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL